# Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)

> **NCT06333990** · PHASE3 · RECRUITING · sponsor: **Foundation for Advancing Veterans' Health Research** · enrollment: 146 (estimated)

## Conditions studied

- Mild Traumatic Brain Injury

## Interventions

- **DRUG:** Quetiapine Fumarate
- **DRUG:** TAU

## Key facts

- **NCT ID:** NCT06333990
- **Lead sponsor:** Foundation for Advancing Veterans' Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-09
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 146 (ESTIMATED)
- **Last updated:** 2025-07-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06333990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06333990, "Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06333990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*